In line with these findings, B7H4 CAR T cell therapies, despite controlling cancer outgrowth, their long-term engraftment of B7H4 CAR T cells led to mediated lethal, off-tumour toxicity that was likely due to broad expression of B7H4 in healthy mouse organs [156]. Here, VTCN1 is linked to cancer.